期刊文献+

Lp-PLA2与冠心病冠状动脉病变程度的相关性分析 被引量:2

Correlation Between Lp-PLA2 and the Severity of Coronary Artery Disease in Coronary Heart Disease
下载PDF
导出
摘要 目的探讨血浆脂蛋白相关磷脂酶A2(Lp-PLA2)水平与冠心病冠状动脉病变程度的相关性。方法选取2019年9~12月我院接受治疗的100例冠心病患者作为冠心病组,根据冠状动脉病变程度分为轻微病变、轻中度病变、中度病变、中重度病变、重度病变、极重度病变,另选取31例同期在我院健康体检者31名作为健康对照组,比较冠心病组不同冠状动脉病变程度患者冠脉Gensini积分,冠心病组与健康对照组Lp-PLA2水平,并分析其与冠心病冠状动脉病变程度的相关性。结果冠心病组中冠状动脉轻微病变者23例,轻中度病变者21例,中度病变者17例,中重度病变者19例,重度病变者11例,极重度病变者9例;其中轻微病变者冠脉Gensini积分低于轻中度病变者、中度病变者、中重度病变者、重度病变者、极重度病变者(P<0.05);极重度病变者Lp-PLA2水平最高,重度病变者、中重度病变者、中度病变者、轻中度病变者、轻微病变者、健康对照组次之,组间比较,差异有统计学意义(P<0.05);Pearson相关性分析显示,Lp-PLA2水平与冠脉Gensini积分呈正相关(r=0.841,P<0.05)。结论Lp-PLA2与冠心病冠状动脉病变程度存在一定相关性,临床可通过检测Lp-PLA2评估冠心病患者冠状动脉的狭窄程度。 Objective To investigate the correlation between the level of plasma lipoprotein-related phospholipase A2(Lp-PLA2)and the severity of coronary artery disease in coronary heart disease.Methods 100 patients with coronary heart disease who received treatment in our hospital from September to December 2019 were selected as the coronary heart disease group.According to the degree of coronary artery disease,it was divided into mild disease,mild to moderate disease,moderate disease,moderate to severe disease,severe disease,and extremely severe disease.Another 31 cases were selected during the same period in our hospital who received routine health examination and proved to be healthy.Volunteers as a healthy control group compared the coronary Gensini scores of patients with different coronary artery lesions in the coronary heart disease group,the Lp-PLA2 levels in the coronary heart disease group and the healthy control group,and analyzed its correlation with the coronary artery lesions of coronary heart disease.Results In the coronary heart disease group,there were 23 cases of mild coronary artery disease,21 cases of mild to moderate disease,17 cases of moderate disease,19 cases of moderate to severe disease,11 cases of severe disease,and 9 cases of extremely severe disease;among them,there were mild disease.The coronary Gensini scores were lower than those with mild to moderate lesions,moderate lesions,moderate to severe lesions,severe lesions,and extremely severe lesions(P<0.05);Lp-PLA2 for extremely severe lesions level was the highest,followed by patients with severe disease,moderate to severe disease,moderate disease,mild to moderate disease,mild disease,and healthy control group(P<0.05);Pearson correlation Sexual analysis showed that the level of Lp-PLA2 was positively correlated with the coronary Gensini score(r=0.841,P<0.05).Conclusion There was a certain correlation between the level of Lp-PLA2 and the degree of coronary artery disease in coronary heart disease.Clinically,the level of Lp-PLA2 could be used to assess the degree of coronary artery stenosis in patients with coronary heart disease.
作者 白雪莹 BAI Xue-ying(Department of Laboratory Medicine,Tianjin Hexi Hospital,Tianjin 300202,China)
出处 《医学信息》 2020年第20期162-163,共2页 Journal of Medical Information
关键词 冠心病 血浆脂蛋白相关磷脂酶A2 冠状动脉 病变程度 冠脉Gensini积分 Coronary heart disease Plasma lipoprotein-related phospholipase A2 Coronary artery Disease degree Coronary Gensini score
  • 相关文献

参考文献6

二级参考文献49

  • 1刘丹,张清华,蒋知新,陈倩,高德路,陈丰,张金树.冠状动脉粥样硬化斑块稳定性与超敏C反应蛋白和妊娠相关血浆蛋白A及基质金属蛋白酶组织抑制剂1表达的关系[J].中国临床康复,2005,9(19):17-19. 被引量:7
  • 2郭纪群,贾恩志,杨志健.吸烟与冠状动脉粥样硬化程度关系的研究[J].南京医科大学学报(自然科学版),2007,27(10):1187-1192. 被引量:16
  • 3Dickstein K, Cohen-Solal A, Filippatos G,et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in Society of Intensive Care Medicine (ESICM) [ J]. Eur J Heart Fail ,2008,10:933 - 989.
  • 4Yancy CW, Jessup M, Bozkurt B, et al. 2013 A CCF/AHA Guideline for the Management of Heart Failure:A Report of the AmericanCol- lege of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[ J]. J Am Coil Cardiol,2013,5 (13) : 735 - 1097.
  • 5Baskurt M, Akttlrk F, Keskin K, et al. Serum high-sensitivity C - re- active protein, amyloid associated protein and N -terminal proBNP levels do not predict reversible myocardial ischaemia [ J ]. Cardio- vasc J Aft,2011,22(2) :85 -89.
  • 6McMurray JJ,Adamopoulos S,Anker SD,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chron- ic Heart Failure 2012 of the European Society of Cardiology. Devel- oped in collaboration with the Heart Failure Association (HFA) of theESC[J]. Eur Heart J,2012,33(9) :1787 -1827.
  • 7Scirlca BM, Sabatine MS, Jarolim P, et al. Assessment of multiple cardiac biomarkers in non - ST - segment elevation acute coronary syndromes: observations from the MERLIN - TIMI 36 trial[ J]. Eur Heart J,2011,32(6) :697 -705.
  • 8Pieroni M, Corti A, Tota B, et al. Myocardial production of chro- mogranin A in human heart: a new regulatory peptide of cardiac function[J]. EurHeart J,2007,28(9):1117-1127.
  • 9Suzuki T, Solomon C, Jenny NS, et al. Lipoprotein-assoeiated phos- pholipase A (2) and risk of congestive heart failure in older adults : the cardiovascular health study[ J ]. Circ Heart Fail, 2009,2 ( 2 ) : 429 - 436.
  • 10Gerber Y, Dunlay SM ,Jaffe AS, et al. Plasma lipoprotein-as sociated phospholipase A2 levels in heart failure:association with mortality in the community[ J]. Atherosclerosis,2009,20 ( 3 ) :593 - 598.

共引文献2116

同被引文献21

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部